NEW YORK, Nov. 27, 2018 /PRNewswire/ -- Nuvo Group, LTD, an emerging leader in maternal-fetal connected health, has named Deb Henretta to the company's Board of Directors. Henretta brings extensive commercialization experience to the Board, as well as significant expertise in digital business transformation in the consumer product and wellness space.

Henretta is currently a Partner at G100 Companies, a private partnership of boutique businesses that deliver solutions, advice, and forums for CEOs of the world's leading companies, and leads digital transformation initiatives at SSA & Company, a privately-held global business operations consulting firm. Earlier in her career, Henretta spent 30 years at Procter & Gamble (P&G), successfully growing & leading several of the company's multi-billion-dollar businesses. While at P&G, Henretta was Group President and Senior Executive Officer of e-Business, working across nearly half of P&G's then $86 billion global business. During her tenure with P&G, she also served as Group President and Senior Executive Officer for P&G's $20 billion Beauty Business, its $20 billion Asian Business, and its $14 billion Baby Care Business.

"We are extremely gratified to have Deb join the Nuvo Group Board of Directors bringing both her extensive knowledge of commercialization within the US market and her deep passion for women's health," said Oren Oz, Founder and Chief Executive Officer of Nuvo Group. "Deb's vast experience in commercializing products that support women and babies, coupled with her intimate knowledge of the consumer products and wellness space gained through her leadership roles with P&G, will no doubt be invaluable in helping to guide Nuvo Group through the process of introducing new offerings to a new generation of physicians and parents."

"In many ways, maternal-fetal health is one of the last frontiers in today's health and wellness landscape, with pregnancy management remaining largely unchanged over the past three decades, all while some 300,000 women worldwide die each year due to preventable, pregnancy-related complications," said Henretta. "I am honored to join the Nuvo Group Board of Directors at such a pivotal time in the company's history and at what I believe is a true inflection point in maternal-fetal health."

In addition to her work with G100 Companies, Henretta currently serves on the Board of Directors at Corning Inc., Meritage Homes Corporation, and privately-held S.C. Johnson, and has previously served on the Board of Directors at Sprint, Staples, and the Singapore Economic Development Board (EDB). In 2008, Henretta was appointed by the U.S. Department of State to the Business Council of the Asia-Pacific Economic Cooperation (APEC), where she was the first woman to serve as Chair of the Council. In this role, she advised top government officials, including U.S. President Barack Obama and former U.S. Secretary of State Hillary Clinton.

Furthermore, Henretta spent seven consecutive years on Fortune's U.S. and International rankings of the 50 Most Powerful Women in Business and is a widely-recognized thought leader in the area of women in leadership. Her work on women, leadership, and corporate boards has appeared in numerous high-profile media outlets including Fortune, Bloomberg, and Huffington Post. Additionally, Henretta has partnered with academics on groundbreaking research on the progress of women on corporate boards with research findings published in Harvard Business Review and MIT Sloan Management Review.

Henretta earned a BA in Mass Communications from St. Bonaventure University and an MA in Advertising from Syracuse University's Newhouse School of Public Communications. She also received an honorary PhD from St. Bonaventure.

About Nuvo Group, LTD
Nuvo Group is committed to transforming pregnancy care for a new generation. Proprietary software solutions combined with innovative product design utilize big data analytics to optimize pregnancy healthcare on a global scale. Nuvo Group leadership is comprised of dedicated data engineers, medical professionals, software designers, and proud parents who share a collective vision to create new solutions for both patients and doctors, creating an immediate impact on maternal care worldwide. Nuvo's initial product offering for healthcare providers is currently undergoing clinical investigation to support FDA clearance and is not yet available for sale in the United States.

For more information, visit: www.nuvocares.com

SOURCE Nuvo Group

Related Links

http://www.nuvocares.com